Unknown

Dataset Information

0

Polybrominated diphenyl ether (PBDE) and poly- and perfluoroalkyl substance (PFAS) exposures during pregnancy and maternal depression.


ABSTRACT:

Background

Experimental studies in rodents suggest that polybrominated diphenyl ethers (PBDEs) and poly- and perfluoroalkyl substances (PFAS) may contribute to depressive symptoms. Few studies have examined the impact of these chemicals on depression in adults.

Objective

To examine the associations between serum PBDE and PFAS concentrations during pregnancy and repeated measures of depressive symptoms in women assessed from pregnancy to 8 years postpartum.

Methods

This study was based on 377 women from the Health Outcomes and Measures of the Environment Study, a birth cohort in Cincinnati, OH (USA). PBDEs (BDE-28, -47, -99, -100, -153, and ∑PBDEs) and PFAS (perfluorooctanoate [PFOA], perfluorooctane sulfonate [PFOS], perfluorohexane sulfonate [PFHxS], perfluorononanoate [PFNA]) were quantified in maternal serum at 16 ± 3 weeks gestation. Depressive symptoms were measured using the Beck Depression Inventory-II (BDI-II) at ~20 weeks gestation and up to seven times during postpartum visits (4 weeks, 1, 2, 3, 4, 5, and 8 years). We used linear mixed models to estimate covariate-adjusted associations between chemical concentrations and repeated measures of BDI-II. Multinomial logistic regression models were used to estimate the relative risk ratios of having a medium or high depression trajectory.

Results

We found that a 10-fold increase in BDE-28 at 16 ± 3 weeks gestation was associated with significantly increased BDI-II scores (β = 2.5 points, 95% confidence interval [CI] 0.8, 4.2) from pregnancy to 8 years postpartum. Significant positive associations were also observed with BDE-47, -100, -153, and ∑PBDEs. A 10-fold increase in ∑PBDEs was associated with a 4.6-fold increased risk (95% CI 1.8, 11.8) of a high trajectory for BDI-II compared to a low trajectory. We observed no significant associations between PFAS and BDI-II scores.

Conclusion

PBDEs during pregnancy were associated with more depressive symptoms among women in this cohort.

SUBMITTER: Vuong AM 

PROVIDER: S-EPMC7275897 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4821747 | biostudies-literature
| S-EPMC5997562 | biostudies-literature
| S-EPMC3569691 | biostudies-literature
| S-EPMC3230439 | biostudies-literature
| S-EPMC4270390 | biostudies-literature
| S-EPMC5567986 | biostudies-literature
| S-EPMC5538570 | biostudies-literature
| S-EPMC6786272 | biostudies-literature
| S-EPMC3285470 | biostudies-literature
| S-EPMC5726937 | biostudies-literature